InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
64,050.00
(
1.85%
)
Post# of 251711
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

investorgold2002

Send PM Follow Ignore
Followers 5
Posts 973
Boards Moderated 0
Alias Born 03/03/2011

investorgold2002

Re: investorgold2002 post# 120712

Saturday, 05/28/2011 9:31:52 AM

Saturday, May 28, 2011 9:31:52 AM

Post# of 251711
page 3 non-infringement is confusing??

Since proving inequitable conduct is going to be pretty tough(see my other message), I am looking at their chance on non-infringement


http://208.78.96.220/2-10-10_Sandoz_reply_re_molecular_weight.pdf

why are they saying the proposed generic's avg mol weight or peak mol weight does not conform to within claimed ranges of branded drug copaxone ?

If so, how will this product be considered equivalent by FDA ????

somebody???
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up